1,169
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association between renal surface nodularity and increased adverse vascular event risk in patients with arterial hypertension

, , , , & ORCID Icon
Article: 2228518 | Received 30 Jun 2022, Accepted 17 Jun 2023, Published online: 27 Jun 2023

References

  • Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–6. doi:10.1038/s41569-021-00559-8.
  • Blood pressure lowering treatment trialists C. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014;384(9943):591–98.doi:10.1016/S0140-6736(14)61212-5
  • Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74(1):120–31. doi:10.1053/j.ajkd.2018.12.044.
  • Mule G, Castiglia A, Cusumano C. Subclinical kidney damage in hypertensive patients: a renal window opened on the cardiovascular system. Focus on microalbuminuria. Adv Exp Med Biol. 2017;956:279–306.
  • Duan X, Rule AD, Elsherbiny H, Vrtiska TJ, Avula RT, Alexander MP, Lerman LO, McCollough CH. Automated assessment of renal cortical surface roughness from computerized tomography images and its association with age. Acad Radiol. 2014;21(11):1441–45. doi:10.1016/j.acra.2014.05.014.
  • Denic A, Alexander MP, Kaushik V, Lerman LO, Lieske JC, Stegall MD, Larson JJ, Kremers WK, Vrtiska TJ, Chakkera HA, et al. Detection and clinical patterns of nephron hypertrophy and nephrosclerosis among apparently healthy adults. Am J Kidney Dis. 2016;68(1):58–67. doi:10.1053/j.ajkd.2015.12.029.
  • Viazzi F, Muiesan ML, Schillaci G, Salvetti M, Pucci G, Bonino B, Signori A, Pontremoli R. Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis. J Hypertens. 2016;34(9):1689–97. doi:10.1097/HJH.0000000000000991.
  • Zhou J, Ding J, Chen J, Wu Q, Xiang D, Xing W, Katsuya T. Association between quantitative classification of renal surface nodularity and early renal injury in patients with arterial hypertension. Int J Hypertens. 2022;2022:1–7. doi:10.1155/2022/1553700.
  • Levey AS, Stevens LA, Schmid CH, Zhang Y(, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. doi:10.7326/0003-4819-150-9-200905050-00006.
  • Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911. doi:10.1016/S0140-6736(14)60685-1.
  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13. doi:10.1016/s0140-6736(02)11911-8.
  • Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, Kaptoge S, Whitlock G, Qiao Q, Lewington S, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174. doi:10.1371/journal.pone.0065174.
  • Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, Jenkins MP, Thompson MM, Evangelista A, Yeh JSM, et al. Aortic dissection. Nat Rev Dis Primers. 2016;2(1):16053. doi:10.1038/nrdp.2016.53.
  • Ding J, Zhou J, Wang K, Jiang Z, Xing W. Association of renal surface nodularity with arterial hypertension compared to normotensive patients. Acta radiol. 2023;64(3):1222–27. doi:10.1177/02841851221106597.
  • Hommos MS, Glassock RJ, Rule AD. Structural and functional changes in human kidneys with healthy aging. J Am Soc Nephrol. 2017;28(10):2838–44. doi:10.1681/ASN.2017040421.
  • Furuichi K, Shimizu M, Okada H, Narita I, Wada T. Clinico-pathological features of kidney disease in diabetic cases. Clin Exp Nephrol. 2018;22(5):1046–51. doi:10.1007/s10157-018-1556-4.
  • Smith EA. Pyelonephritis, renal scarring, and reflux nephropathy: a pediatric urologist’s perspective. Pediatr Radiol. 2008;38(Suppl S1):S76–82. doi: 10.1007/s00247-007-0587-x.
  • Kong W, Hu Z. Unique imaging findings in fibromuscular dysplasia of renal arteries: a case report. Med. 2018;97(46):e12815. doi:10.1097/MD.0000000000012815.
  • De Rosa S, Samoni S, Ronco C. Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care. Crit Care. 2016;20(1):69. doi:10.1186/s13054-016-1218-4.
  • Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082–90. doi:10.1161/STROKEAHA.108.540781.
  • Gokhale S, Caplan LR, James ML. Sex differences in incidence, pathophysiology, and outcome of primary intracerebral hemorrhage. Stroke. 2015;46(3):886–92. doi:10.1161/STROKEAHA.114.007682.
  • Ventura-Clapier R, Piquereau J, Garnier A, Mericskay M, Lemaire C, Crozatier B. Gender issues in cardiovascular diseases. Focus Energy Metabol Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165722. doi:10.1016/j.bbadis.2020.165722.
  • EUCCS G, Regitz-Zagrosek V, Oertelt-Prigione S. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37(1):24–34. doi:10.1093/eurheartj/ehv598.
  • Nwoha PU, Okoro FO, Nwoha EC, Chukwu FN, Nwoha CO, Ogoko NC, Nwoha PN, Idaguko CA, Obi AU, Agwu EM, et al. Sex, knowledge, and attitude of stroke survivors attending Bebe Herbal Center on risk factors before and after stroke. Stroke Res Treat. 2021;2021:1–8.
  • Vaccarezza M, Papa V, Milani D, Gonelli A, Secchiero P, Zauli G, Gemmati D, Tisato V. Sex/gender-specific imbalance in CVD: could physical activity help to improve clinical outcome targeting CVD molecular mechanisms in women? Int J Mol Sci. 2020;21(4):1477. doi:10.3390/ijms21041477.
  • Kalkonde YV, Alladi S, Kaul S, Hachinski V. Stroke prevention strategies in the developing world. Stroke. 2018;49(12):3092–97. doi: 10.1161/STROKEAHA.118.017384.
  • Collaborators GBDS, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, Abd-Allah F, Abdelalim A, Abraha HN, Abu-Rmeileh NM, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–58. doi:10.1016/S1474-4422(19)30034-1.
  • Tsai CF, Sudlow CLM, Anderson N, Jeng JS. Variations of risk factors for ischemic stroke and its subtypes in Chinese patients in Taiwan. Sci Rep. 2021;11(1):9700. doi:10.1038/s41598-021-89228-x.